These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

934 related articles for article (PubMed ID: 25585993)

  • 41. Pharmacokinetics of levodopa, carbidopa, and 3-O-methyldopa following 16-hour jejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients.
    Nyholm D; Odin P; Johansson A; Chatamra K; Locke C; Dutta S; Othman AA
    AAPS J; 2013 Apr; 15(2):316-23. PubMed ID: 23229334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advanced therapies in Parkinson's disease: Long-term retrospective study.
    Merola A; Espay AJ; Romagnolo A; Bernardini A; Rizzi L; Rosso M; Espay KJ; Zibetti M; Lanotte M; Lopiano L
    Parkinsonism Relat Disord; 2016 Aug; 29():104-8. PubMed ID: 27215392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Best practice in placement of percutaneous endoscopic gastrostomy with jejunal extension tube for continuous infusion of levodopa carbidopa intestinal gel in the treatment of selected patients with Parkinson's disease in the Nordic region.
    Dam-Larsen S; Darkahi B; Glad A; Gleditsch D; Gustavsson L; Halttunen J; Johansson KE; Pischel A; Reiertsen O; Törnqvist B; Zebski H
    Scand J Gastroenterol; 2015; 50(12):1500-7. PubMed ID: 26083798
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Problems related to levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.
    Udd M; Lyytinen J; Eerola-Rautio J; Kenttämies A; Lindström O; Kylänpää L; Pekkonen E
    Brain Behav; 2017 Jul; 7(7):e00737. PubMed ID: 28729942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Levodopa-carbidopa intrajejunal infusion in Parkinson's disease: untangling the role of age.
    Morgante F; Oppo V; Fabbri M; Olivola E; Sorbera C; De Micco R; Ielo GC; Colucci F; Bonvegna S; Novelli A; Modugno N; Sensi M; Zibetti M; Lopiano L; Tessitore A; Pilleri M; Cilia R; Elia AE; Eleopra R; Ricciardi L; Cossu G
    J Neurol; 2021 May; 268(5):1728-1737. PubMed ID: 33354739
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Direct switch from conventional levodopa to stalevo (levodopa/carbidopa/entacapone) improves quality of life in Parkinson's disease: results of an open-label clinical study].
    Litvinenko IV; Odinak MM; Mogil'naia VI; Sologub OS; Sakharovskaia AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):51-4. PubMed ID: 19156087
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diphasic dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion in Parkinson's disease.
    Meloni M; Solla P; Mascia MM; Marrosu F; Cannas A
    Parkinsonism Relat Disord; 2017 Apr; 37():92-96. PubMed ID: 28063683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion.
    Zibetti M; Romagnolo A; Merola A; Priano L; Montanaro E; Angrisano S; Tribolo A; Cicolin A; Lopiano L
    J Neurol; 2017 Jun; 264(6):1085-1090. PubMed ID: 28424899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Experience with levodopa/carbidopa intestinal gel in the treatment of advanced Parkinson's disease in Hungary].
    Nagy H; Takáts A; Tóth A; Bereczki D; Klivényi P; Dézsi L; Dibó G; Vécsei L; Kovács N; Aschermann Z; Komoly S; Varannai L; Zemlényi G; Valikovics A
    Ideggyogy Sz; 2014 Nov; 67(11-12):385-9. PubMed ID: 25720240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease.
    Pålhagen SE; Dizdar N; Hauge T; Holmberg B; Jansson R; Linder J; Nyholm D; Sydow O; Wainwright M; Widner H; Johansson A
    Acta Neurol Scand; 2012 Dec; 126(6):e29-33. PubMed ID: 22690905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Levodopa-Carbidopa Intestinal Gel for Parkinson's Disease over 11 years: One Center's "Real-World" Experience.
    Vekhande C; Hamed M; Tremain G; Mah J; Shetty A; Lazarescu A; Suchowersky O
    Can J Neurol Sci; 2024 May; 51(3):379-386. PubMed ID: 37462070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Initiation and dose optimization for levodopa-carbidopa intestinal gel: Insights from phase 3 clinical trials.
    Lew MF; Slevin JT; Krüger R; Martínez Castrillo JC; Chatamra K; Dubow JS; Robieson WZ; Benesh JA; Fung VS
    Parkinsonism Relat Disord; 2015 Jul; 21(7):742-8. PubMed ID: 25962554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Levodopa Carbidopa Intestinal Gel in Advanced Parkinson's Disease: DUOGLOBE Final 3-Year Results.
    Chaudhuri KR; Kovács N; Pontieri FE; Aldred J; Bourgeois P; Davis TL; Cubo E; Anca-Herschkovitsch M; Iansek R; Siddiqui MS; Simu M; Bergmann L; Ballina M; Kukreja P; Ladhani O; Jia J; Standaert DG
    J Parkinsons Dis; 2023; 13(5):769-783. PubMed ID: 37302039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intestinal levodopa infusion: the Belgian experience.
    Pickut BA; van der Linden C; Dethy S; Van De Maele H; de Beyl DZ
    Neurol Sci; 2014 Jun; 35(6):861-6. PubMed ID: 24379105
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa.
    Othman AA; Rosebraugh M; Chatamra K; Locke C; Dutta S
    J Parkinsons Dis; 2017; 7(2):275-278. PubMed ID: 28211816
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa.
    Santos García D; Martínez Castrillo JC; Puente Périz V; Seoane Urgorri A; Fernández Díez S; Benita León V; Udaeta Baldivieso B; Campolongo Perillo A; Mariscal Pérez N
    Neurodegener Dis Manag; 2016 Jun; 6(3):187-202. PubMed ID: 27075968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
    Nyholm D; Nilsson Remahl AI; Dizdar N; Constantinescu R; Holmberg B; Jansson R; Aquilonius SM; Askmark H
    Neurology; 2005 Jan; 64(2):216-23. PubMed ID: 15668416
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets.
    Othman AA; Dutta S
    Br J Clin Pharmacol; 2014 Jul; 78(1):94-105. PubMed ID: 24433449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Duodenal Levodopa Infusion for Long-Term Deep Brain Stimulation-Refractory Symptoms in Advanced Parkinson Disease.
    Regidor I; Benita V; Del Álamo de Pedro M; Ley L; Martinez Castrillo JC
    Clin Neuropharmacol; 2017; 40(3):103-107. PubMed ID: 28452905
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson's Disease.
    Willows T; Dizdar N; Nyholm D; Widner H; Grenholm P; Schmiauke U; Urbom A; Groth K; Larsson J; Permert J; Kjellander S
    J Parkinsons Dis; 2017; 7(4):719-728. PubMed ID: 28984615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.